evitria is an established, global antibody expression service provider located in Zurich, Switzerland. We are specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies) and other proteins.With a track record of more than 100,000 (as of 2022) transfections performed and more than 17,000 antibodies / antibodybased molecules expressed and purified for our clients from the Americas, Europe,... Read More about evitria AG